Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Silexion Therapeutics (NASDAQ:SLXN) through any online brokerage.
Other companies in Silexion Therapeutics’s space includes: Alzamend Neuro Inc (NASDAQ:ALZN), Immuron Ltd (NASDAQ:IMRN), Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Quoin Pharmaceuticals Ltd (NASDAQ:QNRX) and BioRestorative Therapies Inc (NASDAQ:BRTX).
Silexion Therapeutics has a consensus price target of $5.50.
The stock price for Silexion Therapeutics (NASDAQ: SLXN) is $2.68 last updated December 16, 2025 at 9:07 AM EST.
There are no upcoming dividends for Silexion Therapeutics.
Silexion Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Silexion Therapeutics.
Silexion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.